Insiders · Profile

MacKay-Dunn R. Hector

Director at Aurinia Pharmaceuticals. Filing since 11 May 2021. CIK 0001838521

Company
Date
Role
Action
Shares
Amount
Of holding
21 May 2024
Director
Sold at will
5,630
$32.32K
23.2%
23 May 2023
Director
Sold at will
4,818
$54.25K
16.6%
9 Mar 2022
Director
Bought
5,000
$54.99K
83.3%
12 May 2021
Director
Bought
3,000
$33.80K
100%
11 May 2021
Director
Bought
1,500
$16.73K
100%
5 decisions on file.